Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one

EU orphan designation number: EU/3/12/970   
Active ingredient: 6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Pharma Gateway AB
Johanneslundsvägen 2, Oxfordhuset, 194 81 Upplands Väsby, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/03/2012 Orphan Designation EMA/OD/138/11 (2012)1535 of 05/03/2012
04/02/2015 Transfer of orphan designation EMA/OD/138/11/T/01 (2015)639 of 02/02/2015